ADC Therapeutics SA (ADCT)

ADC Therapeutics SA (ADCT) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $217M; returns 1 day -10.0%, 1 week +2.9%, 1 year -64.6%.

ADC Therapeutics SA (ADCT) is a commercial-stage biotechnology company specializing in antibody drug conjugates (ADCs) for cancer treatment. Their primary focus is on hematological malignancies and solid tumors.

Groups ADCT belongs to

• Antibody-Drug Conjugates
• Biotechnology
• Oncology
• Cancer Therapeutics
• Hematologic Malignancies
• Biopharmaceutical
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Antibody Therapeutics

ADCT financial model: income statement, cash flow and balance sheet